Investigating genetic factors in ALS and FTD using whole genome sequencing data.
Official title: Comprehensive Harmonization and Analysis of Case/Control Whole Genome Sequencing Data from the ALS/FTD Compute Project
Funded at Univ of Massachusetts Med Sch Worcester · NIH-10592917 · Data updated 2026-11-12
This study is looking at the genes behind ALS and Frontotemporal Dementia to find out what might cause these conditions, with the hope that understanding these genetic factors can lead to better treatments for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of Massachusetts Med Sch Worcester NIH-funded |
| Lab location | 1 site (Worcester, United States) |
| Project start | February 1, 2023 |
| Project end | July 31, 2025 |
| Funding year | 2023 |
| Award (this year) | $1,630,264 |
| NIH project number | 1R61NS130604-01 |
| Project ID | NIH-10592917 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals diagnosed with ALS or FTD, as well as their family members who may carry genetic risk factors.
✕Less likely to help
Patients with other unrelated neurodegenerative disorders may not receive direct benefits from this research.
What this research studies
This research focuses on understanding the genetic causes of Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD) by analyzing whole genome sequencing data. The project aims to harmonize and combine data from various major sequencing efforts across the United States to identify rare genetic variants and structural changes that may contribute to these neurodegenerative diseases. By leveraging large cohorts of data, the research seeks to uncover previously unexplained genetic factors that could lead to better understanding and treatment options for patients. Patients may benefit from advancements in genetic insights that could inform future therapies and interventions.
Why it matters
Potential benefit: If successful, this research could lead to new insights into the genetic underpinnings of ALS and FTD, potentially improving diagnosis and treatment options for patients.
How similar studies have gone: Previous research has shown success in identifying genetic factors in ALS and FTD, but this project aims to expand on those findings with a novel approach using harmonized whole genome sequencing data.
Where this research is happening
-
Univ of Massachusetts Med Sch Worcester
Worcester, United States Active
Researchers
- Principal investigator: Landers, John E — Univ of Massachusetts Med Sch Worcester
- Study coordinator: Landers, John E
Related research
Other NIH-funded projects on the same topics.
-
Understanding HIV-1 Env shapes to boost immune attack against infected cells
Aimed at helping people living with HIV, this project explores how specific HIV-1 envelope structures attract or resist immune attack so future therapies could better help the body clear hidden virus.
-
Reprogramming metabolism to power alternative fat-burning modes
A new project will explore how fat cells burn calories in different ways to help combat obesity.
-
Silencing an Extra Chromosome to Help Down Syndrome and Related Conditions
A patient-friendly plan to use a gene-based approach to quiet an extra chromosome in cells and a mouse model to reduce disease-related effects in Down syndrome and other chromosomal imbalance disorders.
-
Gut microbes and brain function in autism
Researchers are exploring how gut bacteria may influence brain signals and behavior in autism, using worm models to uncover possible links that could someday inform human therapies.
-
Chlamydia and gonorrhea interaction: how host interferons influence co-infection
A human-health focused project looks at how the body’s interferon signals during chlamydia infection affect the way gonorrhea behaves, with potential implications for people vulnerable to both infections.
-
Conquering High Blood Pressure in Vietnamese Cities
A program to adapt and test a proven plan for lowering high blood pressure in urban Vietnam using a mobile health platform and integrated care approach.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.